Bioavailability comparison
Injectable peptides delivered subcutaneously achieve near 100% bioavailability. The peptide enters tissue directly, avoiding digestive degradation entirely. This remains the gold standard for therapeutic peptide delivery. Oral peptides typically show 0.7-2% bi
This source-based comparison does not add nutrition values, ratings or a recommended winner.
- Injectable peptides delivered subcutaneously achieve near 100% bioavailability. The peptide enters tissue directly, avoiding digestive degradation entirely. This remains the gold standard for therapeutic peptide delivery.
- Oral peptides typically show 0.7-2% bioavailability without enhancement technologies. Even the oral semaglutide tablet (Rybelsus), which uses the permeation enhancer SNAC, achieves only about 1% bioavailability. To compensate, the oral dose is over 200 times higher than the injectable dose.
- For research peptides sold as capsules, bioavailability data is often unavailable. Manufacturers rarely conduct the pharmacokinetic studies needed to determine what percentage of the oral dose actually reaches circulation.